Private Label Skin Care recalled its 7 oz Acne Treatment on September 12, 2025. Elevated levels of benzene prompted the recall, classified as Class II. The affected product was distributed in California and Georgia only.
Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.
Consumers and healthcare providers should stop using this product immediately. Contact Private Label Skin Care Inc. or your healthcare provider for guidance. Notification method: Letter
The recalled product is mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz (201 g). It includes Lot numbers 58170A and 58172A, with an expiration date of September 2025.
The recall stems from chemical contamination due to elevated benzene levels found in the product. Benzene is a known carcinogen, raising concerns about long-term health effects.
There have been no reported injuries or incidents associated with this recall. It is classified as a Class II recall, suggesting a potential risk of temporary or medically reversible adverse health consequences.
Stop using the product immediately. Contact Private Label Skin Care Inc. or your healthcare provider for further guidance.
For more information, visit the FDA's recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0666-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.